| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/02/2003 | EP1267897A1 Treatment of congestive heart failure by pretreated autologous blood |
| 01/02/2003 | EP1267896A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 01/02/2003 | EP1267893A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 01/02/2003 | EP1267892A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome |
| 01/02/2003 | EP1267891A2 Antiadhesive carbohydrates |
| 01/02/2003 | EP1267889A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 01/02/2003 | EP1267885A1 Male contraceptive formulation comprising norethisterone |
| 01/02/2003 | EP1267882A2 Apoptosis inhibitor with prostaglandin structure |
| 01/02/2003 | EP1267878A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/02/2003 | EP1267875A1 Sigma receptor ligands and their medical uses |
| 01/02/2003 | EP1267874A2 Therapeutic uses of ppar mediators |
| 01/02/2003 | EP1267873A2 A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
| 01/02/2003 | EP1267872A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 01/02/2003 | EP1267871A2 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267860A1 Butylnitrone containing compositions for inhibition of cancer development |
| 01/02/2003 | EP1267857A1 Method of inhibiting the expression of inflammatory cytokines and chemokines |
| 01/02/2003 | EP1267855A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 01/02/2003 | EP1267853A2 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 01/02/2003 | EP1267851A2 Method and compositions for preventing hormone induced adverse effects |
| 01/02/2003 | EP1267848A1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1267834A1 Cationic liposomes |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267803A2 Compositions and methods for treating hair loss using c 16? - c 20? aromatic tetrahydro prostaglandins |
| 01/02/2003 | EP1267800A1 Methods of modulating hair growth |
| 01/02/2003 | EP1267760A2 Medical procedure |
| 01/02/2003 | EP1267616A1 Methods of modulating hair growth |
| 01/02/2003 | EP1073452B1 Use of deltorphin for treating cytokine mediated hepatic injury |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/02/2003 | EP1019370B1 Ace-inhibitor nitric salts |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 01/02/2003 | EP0925286B1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 01/02/2003 | EP0915859B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/02/2003 | EP0883401B1 At1 receptor antagonist for the stimulation of apoptosis |
| 01/02/2003 | EP0828727B1 Cyclohexyl dihydrobenzofuranes |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/02/2003 | EP0745131B1 Targeting gene therapy |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/01/2003 | CN1388758A Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1387875A Recipe and prepn process of spleen and kidney invigorating medicine |
| 01/01/2003 | CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 01/01/2003 | CN1097465C Fatigue resisting composition |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 01/01/2003 | CN1097459C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500934 Bivalent agonists for G-protein coupled receptors |
| 12/31/2002 | US6500866 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease |
| 12/31/2002 | US6500843 Inhibitors of rotamase enzyme activity |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500839 CRF receptor antagonists and methods relating thereto |
| 12/31/2002 | US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500802 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 12/31/2002 | US6500800 Composition and method for causing photodynamic damage to target cells |
| 12/31/2002 | US6500654 Cardiac-related ankyrin-repeat protein kinase |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500472 For enriching foods or beverages, anemia treatment |
| 12/31/2002 | US6500432 Method to enhance an immune response of nucleic acid vaccination |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/31/2002 | US6500427 One-component tissue adhesive and a process for the production thereof |
| 12/31/2002 | US6500409 Oral antigingivitis composition comprising an orally acceptable vehicle of a combination of a noncationic halogenated hydroxydiphenyl ether and an extract of magnolia cortex, the bark of magnolia officinalis such as magnolol |
| 12/31/2002 | CA2227814C Substituted benzylaminopiperidine compounds |
| 12/31/2002 | CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/31/2002 | CA2094121C 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 12/28/2002 | CA2391205A1 Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| 12/27/2002 | WO2002103361A1 Method for identification of agents for the treatment of diabetes |
| 12/27/2002 | WO2002103355A1 Preventives/remedies for heart diseases |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103029A2 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 12/27/2002 | WO2002103027A1 Glycoprotein and process for producing the same |
| 12/27/2002 | WO2002103006A1 Guanosine triphosphate-binding protein-coupled receptors |
| 12/27/2002 | WO2002103005A1 Guanosine triphosphate-binding protein-coupled receptors |
| 12/27/2002 | WO2002103002A2 Gene associated with leishmania parasite virulence |
| 12/27/2002 | WO2002102996A1 Male contraceptives |
| 12/27/2002 | WO2002102978A2 Human growth hormone antagonists |
| 12/27/2002 | WO2002102853A2 Cd4-specific antibody trx1 and uses therefor |
| 12/27/2002 | WO2002102845A1 Process for producing silk fibroin-origin functional polypeptide and utilization thereof |
| 12/27/2002 | WO2002102833A1 Novel endomorphine derivatives |